First Patent Application For Dual Gene Therapy Targeting The Aging Process

20 June 2016

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging In 2015 the CEO...

Read more

Bioviva Talks At The 2b Ahead Thinktank Future Congress In Germany

18 June 2016

The 2b AHEAD ThinkTank Future Congress ranks as one of the most attractive events in the European innovation scene. For the last 15 years,...

Read more

First Gene Therapy Successful Against Human Aging

21 April 2016

American woman gets biologically younger after gene therapies Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully...

Read more

Deep Knowledge Life Sciences And Bioviva Announce Partnership

19 April 2016

London-based investment fund brings Seattle-based biotech startup into its portfolio. London, U.K., 19 April 2016 Summary: Seattle-based biotech startup BioViva USA Inc. and London-based...

Read more

Alzheimer’s Cure

7 October 2015

Reversing Alzheimer’s by Lengthening Telomeres There are telomere lengthening compounds available right now for use in research labs. They are not currently available for...

Read more

Bioviva And Telocyte

2 October 2015

BioViva would like to thank Dr Michael Fossel for this blog spot and in recognizing the importance of our work. BioViva will be using...

Read more

The Telomeres-P53-pgc Aging Axis

27 August 2015

This 2011 paper by Dr DePinho builds on previous papers and his theory of the “telomere-p53-PGC axis”. This is a big reason along with...

Read more

Gene therapy is the future

15 August 2015

BioViva, an ambitious biotech startup, aims to cure diseases using gene therapy. It is the first company to recognize aging as a disease and...

Read more